• Home
  • Search Results
  • Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING.

Novel c-di-GMP recognition modes of the mouse innate immune adaptor protein STING.

Acta crystallographica. Section D, Biological crystallography (2013-03-23)
Ko-Hsin Chin, Zhi-Le Tu, Yi-Che Su, Yu-Jen Yu, Hui-Chen Chen, Yuan-Chao Lo, Chin-Pan Chen, Glen N Barber, Mary Lay-Cheng Chuah, Zhao-Xun Liang, Shan-Ho Chou

The mammalian ER protein STING (stimulator of interferon genes; also known as MITA, ERIS, MPYS or TMEM173) is an adaptor protein that links the detection of cytosolic dsDNA to the activation of TANK-binding kinase 1 (TBK1) and its downstream transcription factor interferon regulatory factor 3 (IFN3). Recently, STING itself has been found to be the direct receptor of bacterial c-di-GMP, and crystal structures of several human STING C-terminal domain (STING-CTD) dimers in the apo form or in complex with c-di-GMP have been published. Here, a novel set of structures of mouse STING-CTD (mSTING(137-344)) in apo and complex forms determined from crystals obtained under different crystallization conditions are reported. These novel closed-form structures exhibited considerable differences from previously reported open-form human STING-CTD structures. The novel mSTING structures feature extensive interactions between the two monomers, a unique asymmetric c-di-GMP molecule with one guanine base in an unusual syn conformation that is well accommodated in the dimeric interface with many direct specific interactions and two unexpected equivalent secondary peripheral c-di-GMP binding sites. Replacement of the amino acids crucial for specific c-di-GMP binding in mSTING significantly changes the ITC titration profiles and reduces the IFN-β reporter luciferase activity. Taken together, these results reveal a more stable c-di-GMP binding mode of STING proteins that could serve as a template for rational drug design to stimulate interferon production by mammalian cells.

Product Number
Product Description

Guanosine 3′,5′-cyclic monophosphate, ≥98% (HPLC), powder